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Key points: 
 Reducing Na+ intake reduces the partial pressure of oxygen in the renal cortex and 
activates the renin-angiotensin-aldosterone system. 
 In the absence of high blood pressure, these consequences of dietary Na+ reduction 
may be detrimental for the kidney. 
 In a normotensive animal experimental model, reducing Na+ intake for two weeks 
increased renal oxygen consumption that was normalized by mineralocorticoid 
receptor blockade. Furthermore, blockade of angiotensin II AT1 receptor restored 
cortical partial pressure of oxygen by improving oxygen delivery.  
 This shows that increased renin-angiotensin-aldosterone system contributes to 
increased oxygen metabolism in the kidney after two weeks of low Na+ diet. 
 The results provide insights to dietary Na+ restriction in the absence of high blood 
pressure, and its consequences for the kidney.  
 
Abstract 
Reduced Na+ intake reduces the partial pressure of oxygen (PO2) in the renal cortex. Upon 
reduced Na+ intake, reabsorption along the nephron is adjusted with activation of the renin-
angiotensin-aldosterone system (RAAS). Thus, we studied the effect of reduced Na+ intake 
on renal oxygen homeostasis and function in rats, and the impact of intrarenal angiotensin II 
AT1 receptor blockade using candesartan and mineralocorticoid receptor blockade using 
canrenoic acid potassium salt (CAP).  
Male Sprague-Dawley rats were fed standard rat chow containing normal (0.25%) and low 
(0.025%) Na+ for two weeks. Animals were anesthetized (thiobutabarbital 120 mg/kg) and 
surgically prepared for kidney oxygen metabolism and function studies before and after acute 
intrarenal arterial infusion of candesartan (4.2µg/kg) or the intravenous infusion of CAP 
(20mg/kg). 
Baseline mean arterial pressure and renal blood flow were similar in both dietary groups. 
Fractional Na+ excretion and cortical oxygen tension were lower, and renal oxygen 
consumption was higher in low Na
+ groups. Neither candesartan nor CAP impacted upon 
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cortical oxygen tension, on low Na+ group. Fractional Na+ excretion was increased and 
oxygen consumption reduced on low Na+ group after CAP. 
These results suggest that blockade of angiotensin II AT1 receptors have a major impact upon 
oxygen delivery during normal and low Na+, while aldosterone receptors mainly affect 
oxygen metabolism following two weeks of low Na+ diet. 
Keywords: Low Na+, kidney, oxygen consumption, hypoxia, angiotensin II, aldosterone. 
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Introduction 
Like in other organs, renal oxygen content is determined by delivery and demand. Renal 
autoregulation maintains renal blood flow (RBF) within a high amplitude of perfusion 
pressure to maintain a stable glomerular filtration rate (GFR). However, since RBF is not 
under metabolic control, increasing renal metabolism can have a detrimental impact in tissue 
integrity if not matched by oxygen delivery. The partial pressure of oxygen (PO2) is 
heterogeneous in the renal parenchyma, it is relatively high in the highly perfused renal 
cortex and decreases towards the scarcely perfused inner renal medulla (Brezis et al., 1984; 
Brezis et al., 1994b). Low PO2 is a common observation in end stage renal disease, regardless 
of its etiology (Hirakawa et al., 2017). We and others have shown that prolonged increased 
oxygen consumption (QO2), low PO2 along the renal parenchyma and consequent renal 
hypoxia are associated with long-term renal impairment (Welch et al., 2001; Manotham et 
al., 2004; Matsumoto et al., 2004; Palm et al., 2004; Friederich-Persson et al., 2013; Ow et 
al., 2014; Franzen et al., 2016; Emans et al., 2018). In physiological conditions, the major 
determinant of renal oxygen metabolism is Na+ transport (Brezis et al., 1994a). Increased 
kidney QO2 can result from increased tubular Na
+ reabsorption to either compensate for 
glomerular hyperfiltration (Körner et al., 1994) or oxidative stress-induced reduction of 
electrolyte transport efficiency (Palm et al., 2003; Welch et al., 2003; Welch et al., 2005). 
The majority of Na+ reabsorption occurs in the proximal tubule. Its permeable epithelium 
allows for paracellular ion flux driven by active Na+ transport, resulting in a highly energy 
efficient process (Cohen, 1986; Pei et al., 2016). The downstream segments of the nephron 
have a tighter epithelium and account for refinement of Na+ reabsorption with higher energy 
expenditure to conserve it (Cohen, 1986; O'Neill et al., 2015; Palmer & Schnermann, 2015; 
Layton et al., 2016; Pei et al., 2016). Consequently, increasing Na+ reabsorption in 
downstream segments of the nephron may lead increased total kidney QO2. 
While high Na+ intake is associated with increased blood pressure and higher cardiovascular 
risk, there is lack of evidence for the beneficial effects of Na+ reduction in diet in 
normotensive conditions (Committee on the Consequences of Sodium Reduction in et al., 
2013; Graudal et al., 2014; Kong et al., 2016; Lelli et al., 2018). Reducing Na+ intake can 
reduce high blood pressure, thereby decreasing the risk for cardiovascular events and 
mortality. However, an association of low Na+ diet with overall increased cardiovascular 
disease and mortality has been reported (Midgley et al., 1996; Stolarz-Skrzypek et al., 2011; 
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compensatory activation of the renin-angiotensin aldosterone system (RAAS) (Graudal et al., 
1998; Shao et al., 2013) to the same proportion of Na+ reduction (Graudal et al., 1998). This 
can be detrimental for the kidney and would explain the relatively modest reductions in blood 
pressure observed after Na+ restriction (Graudal et al., 1998). Accordingly, following two 
weeks of Na+ restriction, renal angiotensin II is increased resulting in both glomerular and 
tubulointerstial fibrosis in rats (Shao et al., 2013). Activation of the RAAS affects both 
oxygen delivery and consumption in the kidney. Angiotensin II AT1 receptor activation 
increases renal vascular tone, aldosterone production, Na+ reabsorption mainly in the 
proximal tubule and reactive oxygen species (ROS) production (Onozato et al., 2002; Kobori 
et al., 2007; Banday & Lokhandwala, 2011; Patinha et al., 2013). In addition, aldosterone 
signaling through mineralocorticoid receptors increases Na+ reabsorption in the distal tubule 
and collecting duct and contributes to ROS formation (Garty, 2000; Miyata et al., 2005; 
Udwan et al., 2017; Frindt et al., 2018). It would therefore be expected that reduced dietary 
Na+ intake would increase kidney QO2 due to elevated tubular sodium transport (TNa+) to 
maintain electrolyte balance, which potentially could result in intrarenal tissue hypoxia. 
The pioneering work of Stillman and coworkers demonstrated that the tissue PO2 gradient in 
the kidney was inverted (Stillman et al., 1994). Following chronic administration of a Na+ 
depleted diet, the PO2 was higher in the renal medulla and lower in the cortical region 
(Stillman et al., 1994). This reversal of oxygen gradients may compromise kidney function 
and its long-term consequences are unknown. The mechanistic explanations of these 
alterations are presently undefined, but it may be speculated that the pronounced cortical 
hypoxia during Na+ restriction may be initiated by augmented RAAS signaling in the kidney. 
Prolonged exposure to increased RAAS could potentially explain the reported detrimental 
effects of reduced dietary Na+ intake (Stillman et al., 1994; Midgley et al., 1996; Graudal et 
al., 2014; O'Donnell et al., 2014). In the present study, we tested the hypothesis that low Na+ 
intake results in RAAS activation and a compensatory increase in tubular Na+ reabsorption. 
Furthermore, we hypothesized that low Na+ diet affects renal QO2 as a consequence of 
increased RAAS signaling, resulting in altered oxygen availability.  
Materials and Methods 
Ethical Approval 
All experiments were performed in accordance with the European Convention for the 
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approved by the local Animal Care and Use Committee (approval reference  
5.8.18-13971/2018). Animals were housed in temperature, humidity and light controlled 
environment (12h light-dark cycle), had free access to water and were fed rat chow ad 
libitum. Investigators understand the ethical principles under which The Journal of 
Physiology operates and the present studies comply with its animal ethics checklist.  
 
Animal model 
Age matched (8-9 weeks-old) male Sprague-Dawley rats (Charles River, Sulzfeldt, Germany) 
were fed with either normal (0.25%) or low (0.025%) Na+ diet (R36, Labfor, Stockholm, 
Sweden) during two weeks. Subsequently, animals in each group were subjected to functional 
renal assessments under anesthesia (see below) and further subdivided to yield four groups: 
normal Na+ diet with intrarenal angiotensin II AT1 receptor blockade using candesartan 
(n=13) or mineralocorticoid receptor blockade using canrenoic acid potassium salt (CAP, 
n=11) or low Na+ diet with candesartan (n=12) or CAP (n=9). 
 
Acute experimental protocol 
The experimental protocol is depicted in Fig 1. Rats were terminally anesthetized with 
thiobutabarbital (Inactin, 120 mg/kg, ip), placed on a heating pad set at 37°C and 
tracheostomized. Catheters were placed into the left carotid artery and the left femoral artery 
and vein for blood pressure measurement, blood collection and saline infusion (Ringer 
solution, 5 mL/kg/h), respectively. The bladder was catheterized for urinary drainage. The 
left kidney was exposed by a subcostal flank incision and immobilized in a plastic cup, as 
previously described (Patinha et al., 2013) and the left ureter was catheterized for urine 
collection. A catheter was advanced ~1–2 mm into the left renal artery, through a lumbar 
artery, for precise intrarenal infusion (Lissamine green 10% solution was infused to confirm 
that catheter placement allowed precise intra-renal infusion with uniform distribution). After 
45min of stabilization, measurements were performed before and after drug infusion (Fig 1). 
Candesartan (AstraZeneca, Mölndal, Sweden; 4.2 µg/kg in 200µL), the angiotensin II AT1 
receptor blocker, was slowly infused during 10 min into the kidney via renal artery, 10 min 
after the experimental period started, as previously detailed (Patinha et al., 2013). In another 




This article is protected by copyright. All rights reserved. 
intravenously. At the end of the experiments animals were terminated under anesthesia by 
infusion of saturated potassium chloride or perfusion solution.   
 
Measurements of kidney hemodynamics and oxygen metabolism 
Blood pressure was measured using a transducer (model P23dB; Statham Laboratories, Los 
Angeles, CA, USA) connected to the left carotid artery catheter. Total RBF was measured 
using an ultrasound flow probe (Transonic Systems Inc., Ithaca, NY, USA) placed around the 
left renal artery. These parameters were continuously recorded with a Power Lab instrument 
(AD Instruments, Hastings, UK) connected to a Personal Computer. Glomerular filtration rate 
was estimated by inulin clearance ([3H]-Inulin, American Radiolabeled Chemicals, St. Louis, 
MO, USA, 185 kBq/kg/h). Blood gas parameters were measured from samples drawn from 
the left femoral artery and left renal vein using the iSTAT System (Abbott Laboratories, 
Abbott Park, IL, USA). The left renal vein blood sample was collected using a heparinized 
syringe, in a slow manner to avoid sampling from the vena cava. 
Urine volume was measured gravimetrically, and urinary Na+ concentration was quantified 
by flame spectrophotometry using a multianalyzer (model IL543; Instrumentation Lab, 
Milan, Italy). Protein concentrations were determined using DC Protein Assay according to 
manufacturer instructions (BioRad Laboratories, Hercules, CA, USA). Thiobarbituric acid 
reactive substances (TBARS) were measured in urine and plasma samples. Brifely, 50 µL of 
standards (malondialdehyde-bis-(diethylacetate; Merck-Schuchardt, Schuchardt, Germany) 
and samples were heated with 62.5 µL of thiobarbituric acid (0.67%), 97C, 60 min. Samples 
were immediately cooled down on ice, precipitated with methanol/NaOH mmol/L (91:9) and 
centrifuged 3000 rpm, 5min, RT. Fluorescence was determined on the supernatant (excitation 
532 nm; emission 553 nm; Tecan Safire2, Männedorf, Switzerland).  
Kidney PO2 was determined during the clearance period under anesthesia using modified 
Clark-type oxygen microelectrodes with an outer diameter of the tip of less than 10 μm 
(Unisense, Aarhus, Denmark). Electrodes were two point calibrated in water saturated with 
either Na2S2O5 (PO2 = 0 mmHg) or air (PO2 = 147 mmHg). The oxygen microelectrodes 
were positioned using a micromanipulator in order to measure the cortical and medullary PO2 
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Tissue collection. 
Animals (additional normal n=10 and low n=10 Na+ diet) were anesthetized as previously 
described and the kidneys extracted after ice-cold saline perfusion. The left kidney was 
collected for angiotensin II extraction and quantification and the right kidney was dissected 
and placed in RNA preserving solution (Ambion RNAlater, ThermoFisher Scientific, 
Waltham, MA, USA) or snap frozen with liquid nitrogen.  
 
Angiotensin II extraction and quantification. 
Angiotensin II was extracted from the renal tissue as previously described (Fox et al., 1992). 
Briefly, the left kidney was removed, weighed, rapidly homogenized in cold methanol (10%, 
wt/vol) and stored at -80°C. Samples were thawed, centrifuged (10 min, 4°C) and dried 
overnight in a vacuum centrifuge before extraction. The dried residue was reconstituted in 
sodium phosphate buffer (50 mmol/L, pH 7.4) and applied to phenyl-bounded solid phase 
extraction (SPE) column (Discovery® DSC-Ph SPE Tube, Sigma Aldrich) previously 
conditioned with methanol and equilibrated with water. After washing, angiotensin II was 
eluted from SPE column with 90% methanol in water and dried under vacuum. Angiotensin 
II was measured using Angiotensin II EIA kit (Peninsula Laboratories Inc., San Carlos, CA, 
USA) according to the manufacturer’s instructions. 
 
RNA extraction, cDNA Synthesis and quantification. 
The kidney cortex sections preserved in RNAlater® were used for total RNA extraction using 
RNAqueous®-4PCR (Ambion, Waltham, MA, USA). iScript cDNA Synthesis Kit (BioRad 
Laboratories) was used to synthesize cDNA from total RNA and levels were assessed by real 
time quantitative PCR using SYBR green PCR reagent (LightCycler® FastStart DNA Master 
SYBR Green I, Roche, Mannheim, Germany) and the iCycler PCR system (BioRad 
Laboratories) according to the manufacturer’s instructions. Briefly, amplification reactions 
consisted of 2 µL cDNA, 2 µL Mix (LightCycler® FastStart DNA Master SYBR Green I; 
Roche), 2.5 µL primers mix and 3.5 µL of H2O. Relative gene expressions were calculated 
from 2-∆Ct in relation to β-actin, which was used as housekeeping gene. Primer sequences are 
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Calculations 
Renal vascular resistance (RVR) was calculated as MAP/RBF. The filtration fraction (FF) 
was calculated using the formula FF=GFR/[RBF*(1-Hematocrite)]. In vivo kidney QO2 was 
determined from the product of the arterio-venous difference in oxygen content (O2ct) and 
RBF. Transported Na+ (TNa) was calculated as TNa=[PNa]*GFR-[UNa]*Urine flow,  where 
[PNa] and [UNa] are plasma and urine Na+ concentration, respectively. Fractional Na+ 
excretion (FENa) was estimated from [UNa] * [Pi]/[PNa] * [Ui], where [PNa], [UNa], [Pi] 
and [Ui] are plasma and urine Na+ and inulin concentration, respectively. 
 
All chemicals were from Sigma Aldrich (St. Louis, MO, USA) and of highest grade available 
if not otherwise stated. 
Statistical analysis 
All statistical analysis were performed using Graph Pad Prism (GraphPad Software, San 
Diego, CA, USA). Differences between groups were assessed using two way ANOVA 
followed by uncorrected Fisher’s LSD test. Differences in angiotensin II concentration and 
mRNA expression of angiotensin II AT1a and AT1b receptors were assessed using unpaired t 
test. For all comparisons, p<0.05 was considered statistically significant. Descriptive statistics 
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Results 
Effect of Na+ diet  
Increased RAAS activity in low Na+ group was confirmed by increased intrarenal tissue 
concentration of angiotensin II (Table 2). In the kidney cortex, mRNA expression of 
angiotensin II receptor AT1a was decreased while no alteration was observed in AT1b (Table 
2). Body weight (396±8 vs 396±9 g; NS) and kidney weight (1.28±0.04 vs 1.27±0.03 g; NS) 
were similar between normal and low Na+ groups. Likewise, no difference was observed in 
MAP and RBF (Figs. 2 and 6), GFR, FF, FEK and arterial gas status (Tables 3 and 4) between 
normal and low Na+ groups at baseline. Arterial blood electrolytes, hemoglobin, hematocrit 
and pH, TBARS and protein excretion as well as plasma TBARS were also similar at 
baseline between normal and low Na+ diet groups (Table 3 and 4). Oxygen delivery (Figs. 3A 
and 7A) was similar between normal and low Na+ groups at baseline; however QO2 (Figs. 3B 
and 7B) and fractional O2 extraction (Figs. 3C and 7C) were more than 50% higher in low 
Na+ group when compared with  normal Na+ at baseline. TNa (Fig 4B and 8B) was unaltered 
while FENa (Figs. 4A and 8A) and TNa/QO2 (Figs. 4C and 8C) were more than 30% lower in 
low Na+ groups. This coincided with more than 14% lower cortical (Figs. 5 A and 9A) and 
more than 25% higher medullary PO2 (Figs. 5B and 9B) in the low Na
+ groups at baseline 
when compared with normal Na+ at baseline. 
 
Contribution of RAAS - Effect of angiotensin II AT1 receptor blockade  
Candesartan was used to block angiotensin II AT1 receptors; Infusion of candesartan directly 
into the left kidney via renal artery did not alter MAP (Fig. 2A), GFR, arterial blood gas 
status, electrolytes, hemoglobin, hematocrit or pH (Table 3) in either dietary group. Intrarenal 
infusion of candesartan decreased FF in the normal Na+ group but was without significant 
effect on this variable in the low Na+ group (Table 3). Following candesartan infusion FEK 
and TBARS excretion were increased in the low Na+ group but was without significant effect 
on these variables in the normal Na+ group (Table 3). After candesartan infusion proteinuria 
was increased in both groups (Table 3). RBF (Fig. 2B) and renal oxygen delivery (Fig. 3A) 
had more than 35% increase in both normal and low Na+ groups following intrarenal 
candesartan infusion. QO2 (Fig. 3B) and fractional oxygen extraction (Fig. 3C) were more 
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low Na+ group. Intrarenal candesartan infusion more than doubled FENa in both normal and 
low Na+ groups (Fig 4A). TNa (Fig. 4B) was not significantly altered following candesartan 
infusion in both groups and TNa/QO2 (Fig. 4C) was more than 40% decreased following 
candesartan infusion in the normal Na+ group without significant effect in the low Na+ group. 
Following candesartan infusion, PO2 in the renal cortex of low Na
+ group significantly 
increased to levels comparable with the normal Na+ group at baseline, without altering renal 
medulla PO2 (Figs. 5A and B). 
 
Contribution of RAAS - Effect of aldosterone mineralocorticoid receptor blockade 
CAP was used to block aldosterone receptors; Following CAP infusion no effect was 
observed on MAP, RBF (Fig. 6), GFR or FF (Table 4) in either dietary group when compared 
with baseline levels. Similarly, arterial blood gas status, electrolytes, hemoglobin, hematocrit 
or pH (Table 4) remained unaltered following CAP infusion in normal and low Na+ groups. 
Interestingly, FEK was increased by approximately 7-fold after CAP in the low Na
+ group 
with no significant alteration observed in the normal Na+ group (Table 4). Urinary TBARS 
and protein excretion as well as plasma TBARS were not altered after CAP infusion in both 
groups. After CAP infusion no significant alteration was observed on oxygen delivery (Fig 
7A) in either group; However, QO2 (Fig. 7B) was reduced by 37% in low Na
+ group to levels 
that were comparable with the normal Na+ group at baseline. Fractional oxygen extraction 
(Fig. 7C) was significantly reduced by 42% only on low Na+ group. Following CAP infusion, 
no alteration was observed on FENa (Fig. 8A) in the normal Na
+ group but it increased FENa 
to levels that were comparable with the normal Na+ group at baseline. No effect was observed 
on transported Na+ (Fig. 8B) or TNa/QO2 on both groups after CAP. Finally, no significant 
effect was observed on tissue PO2 in the cortex and medulla following CAP infusion in both 
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Discussion  
The main novel finding of the present study was that reducing Na+ intake for two weeks to 
the extent that intrarenal angiotensin II is increased, in normotensive conditions, increased 
renal QO2 that was completely normalized by mineralocorticoid receptor blockade. 
Furthermore, acute blockade of angiotensin II AT1 receptor restored cortical PO2 by 
improving oxygen delivery. Overall, these data suggest that heightened aldosterone signaling 
promotes an increase in renal QO2 in the low Na
+ group. Interestingly, the normalization of 
cortical PO2 in the low Na
+ group was only achieved during intrarenal angiotensin II AT1 
receptor blockade. This was mediated through an increase in oxygen delivery as opposed to 
alteration of renal QO2, indicating that increased oxygen delivery regulation of renal PO2 
supersedes metabolic demand in this context. 
Urinary Na+ excretion is continuously adjusted to match intake, thus preserving osmotic 
balance. Accordingly, in the present study, normal and low Na+ groups had similar plasma 
electrolyte concentration, MAP, RBF and GFR, but the low Na+ group had lower FENa 
indicating that adjustment to low Na+ intake occurred mainly within the tubular segments. 
The otherwise healthy kidneys of animals in the low Na+ group exhibited altered oxygen 
homeostasis with increased QO2 and decreased Na
+ transport efficiency. This is possibly 
associated with a redistribution of Na+ reabsorption along the tubule (Udwan et al., 2017; 
Frindt et al., 2018), and consequent increase workload in less efficient segments of the 
nephron where the epithelia is tighter and the energy demand is higher when compared with 
the proximal tubule (Cohen, 1986; Palmer & Schnermann, 2015; Layton et al., 2016). Indeed, 
during low Na+ diet, Na+ reabsorption is increased not only in the proximal tubule but also in 
the distal tubule/connecting tubule and collecting duct (Udwan et al., 2017; Frindt et al., 
2018). 
The observed increase in renal QO2 may have long-term detrimental effects. Friederich-
Persson showed that increasing kidney metabolism by increasing mitochondrial QO2 leads to 
tubulointerstitial damage, proteinuria and infiltration of inflammatory cells (Friederich-
Persson et al., 2013). Also, low renal PO2 precedes oxidative stress and proteinuria in 
diabetic mice (Franzen et al., 2016). Likewise, reduced cortical PO2 precedes renal injury in 
angiotensin II-dependent hypertension (Emans et al., 2016). Indicating that the presently 
observed increased QO2 and reduced cortical PO2 induced by low Na
+ diet may lead to renal 
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documented in healthy animals fed a low Na+ diet for two weeks. Furthermore, cortical 
hypoxia measured using BOLD-MRI was reported to be a prognostic marker in the 
progression of chronic kidney disease (Zhou et al., 2018). In agreement with the previous 
report by Stillman et al (Stillman et al., 1994), we also observed increased medullary PO2 in 
the Na+ restricted animals. It may only be speculated that increased proximal Na+ 
reabsorption reduced medullary tubular Na+ load resulting in reduced amount of active 
reabsorption by the medullary nephron segments. Indeed, reduced Na+ intake for four weeks 
significantly reduces medullary thick ascending limb size (Stillman et al., 1994), possibly 
indicating reduced workload in this part of the segment. This would imply that reduced Na+ 
intake reduces the metabolic activity in the renal medulla and therefore also reduces QO2 and 
increases PO2 in this region of the kidney. Contrary, the increased reabsorption in cortical 
nephron segments would increase QO2 and cause hypoxia. It has also been shown in 
normotensive humans with reduced Na+ intake that the increased medullary oxygenation is 
due to enhanced proximal tubular Na+ reabsorption resulting in reduced Na+ delivery and 
workload to the distal, less efficient, tubular segments (Pruijm et al., 2010).These alterations 
could mechanistically explain the abolished cortico-medullary PO2 gradient during reduced 
Na+ intake. 
Low Na+ diet increases intrarenal activity of the RAAS (Schmid et al., 1997; Graudal et al., 
1998; Shao et al., 2013), confirmed in the present study by increased tissue angiotensin II 
concentration in low Na+ group. Low Na+ diet decreased AT1a receptor expression but did not 
affect AT1b receptor expression, this differential regulation is in good agreement with 
previously reported data (Schmid et al., 1997). The AT1a receptor is critical for Na
+ handling 
and blood pressure control (Chen et al., 1997; Oliverio et al., 2000), its downregulation may 
be important to prevent blood pressure increase in the context of high angiotensin II, while 
the AT1b receptors may be more relevant for Na
+ conservation in low Na+ conditions. Indeed, 
during low Na+, AT1b receptors mediate RAAS-dependent stimulation of aldosterone 
production in the adrenal gland (Kitami et al., 1992; Schmid et al., 1997). The Angiotensin 
(1-7)/Mas receptor axis may also be an important contributor for Na+ balance in low Na+ 
conditions. Indeed, the diuretic and natriuretic actions of angiotensin 1-7 are enhanced 
following low Na+ diet, although the blockade of the Mas receptor had no effect on basal Na+ 
excretion (O'Neill et al., 2013; O'Neill et al., 2017). Rearrangements of Na+ reabsorption 
along the tubule during low Na+ diet are mainly attributed to proximal tubule, late distal 
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2018). In these tubular segments, NHE3 and epithelial Na
+ channel (ENaC) are major 
transporters (Palmer & Schnermann, 2015) and under strict regulation by the RAAS (Geibel 
et al., 1990; Garty, 2000; Peti-Peterdi et al., 2002; Banday & Lokhandwala, 2011). We 
therefore tested the effect of angiotensin II AT1 and aldosterone mineralocorticoid receptor 
blockade on oxygen metabolism after two weeks of low Na+ diet. 
Mean arterial pressure remained stable in both groups after angiotensin II AT1 receptor 
blockade, confirming that candesartan infusion into the kidney was accurate and that the 
observed effects were blood pressure independent. RBF and oxygen delivery were increased 
to a similar extent and GFR unaltered, after angiotensin II AT1 receptor blockade in both 
groups. Intriguingly, in the normal Na+ group this was accompanied by an increase in QO2 
while no alteration was observed in the low Na+ group. Also, FENa was increased in both 
groups. Angiotensin II AT1 receptor activation directly influences Na
+ reabsorption namely 
by 1) stimulation Na+/K+ ATPase pump in the basolateral membrane (Yingst et al., 2004); 2) 
stimulation Na+/H+ exchange in the luminal membrane, mainly by activating NHE3 in the 
proximal tubule (Geibel et al., 1990); and 3) Na+/HCO3
- co-transport in the basolateral 
membrane (Geibel et al., 1990). Additionally, the vasoconstrictor effect on efferent arteriole 
reduces the blood flow to peritubular capillaries thus increasing Na+ net reabsorption, 
especially in the proximal tubule. Hence, we propose that angiotensin II AT1 receptor 
blockade mainly affected Na+ reabsorption in the proximal region of the tubule of normal Na+ 
group, promoting higher downstream delivery where Na+ reabsorption is less effective. This 
premise is in line with the effect of inhibiting angiotensin converting enzyme that rapidly 
reduced Na+ reabsorption in the proximal tubule mainly by reducing NHE3, without altering 
blood pressure or GFR (Leong et al., 2006). Our findings also in part corroborate the 
mathematical modeling predictions of NHE3 inhibition resulting in lower Na
+ transport 
efficiency in the otherwise healthy kidney of rats (Layton et al., 2016). The effect of 
Angiotensin II AT1 receptor activation in the stimulation Na
+ reabsorption in the cortical 
collecting duct via ENaC (Peti-Peterdi et al., 2002) may also contribute, to a smaller extent, 
to the observed effects. The present results refer to the whole kidney, one cannot exclude that 
there might be heterogeneity in these parameters at the nephron level (Källskog et al., 1976; 
Inscho et al., 1997)]. 
The lack of effect of angiotensin II AT1 receptor blockade in QO2 of the low Na
+ group may 
also be an extension of the previously stated premise. In the low Na+ group, the downstream 
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increased QO2 and lower tubular transport efficiency, as presently observed. Indicating that 
angiotensin II AT1 receptor is not the only contributor to the overall increased QO2 in low 
Na+ diet. Importantly, the increase of renal oxygen supply maintained cortical PO2 in the low 
Na+ group and increased it in the low Na+ group to similar levels of baseline normal Na+ 
group, restoring the cortico-medulary gradient. The diverse acute effects on renal oxygen 
metabolism in response to angiotensin II AT1 receptor blockade between normal and low Na
+ 
fed animals may also be, to some extent, associated with morphological changes in the outer 
medulla (Stillman et al., 1994) or with increased angiotensin II availability for activation of 
AT2 receptors. 
Similar to what was observed during angiotensin II receptor blockade, aldosterone 
mineralocorticoid receptor blockade did not alter MAP or GFR, when compared with 
baseline in both diets. However, although RBF and oxygen delivery were not altered in both 
diets after mineralocorticoid blockade, QO2 and fractional oxygen extraction were reduced 
along with significantly increased FENa in low Na
+ group when compared with respective 
baseline, with no effect on renal PO2. Suggesting that aldosterone mineralocorticoid receptor 
activation is in part responsible for higher low Na+-induced QO2 in the kidney. Indeed, 
aldosterone mineralocorticoid receptor activation in connecting and collecting duct is of 
major importance for Na+ conservation during low Na+ diet as eliminating it will result in Na+ 
waste in mice (Ronzaud et al., 2007). Plasma aldosterone increases in Na+ depleted rats after 
seven days along with ENaC activity (Frindt et al., 2018). Which is in good agreement with 
the hypothesis that low Na+ diet shifts Na+ reabsorption to less effective sections of the 
tubule, with higher energy requirements to reabsorb Na+ resulting in higher QO2, as presently 
observed. 
High Na+ is generally associated with increased blood pressure and higher risk for 
cardiovascular disease (IntersaltCooperativeResearchGroup, 1988; Mente et al., 2014). 
Accordingly, in hypertensive individuals in which reducing Na+ intake results in reduced 
blood pressure, cardiovascular health benefits are achieved (Cook et al., 2007; Adler et al., 
2014). However, the debate on how much Na+ should be removed from the diet and the ideal 
Na+ intake is still ongoing (Cook et al., 2020). Indeed, although high Na+ intake has been 
demonstrated in numerous studies to have negative cardio-renal effects, drastically reducing 
Na+ intake is also somewhat surprisingly associated with worsen outcome 
(IntersaltCooperativeResearchGroup, 1988; Midgley et al., 1996; Stolarz-Skrzypek et al., 
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2017). The association of Na+ intake and mortality seems to have a U-shaped curve with both 
low and high Na+ diets rendering increased cardiovascular events and mortality. Although, it 
cannot be excluded that the increased risk observed in the low Na+ diet participants may be 
influenced by pre-existing comorbidities such as diabetes and history of cardiovascular 
disease (O'Donnell et al., 2014), which requires further investigation. While the adverse 
effects of high Na+ intake seem to be due to blood pressure effects, the increased risk 
associated with low Na+ intake was unaffected by adjustment for blood pressure, suggesting 
blood pressure independent mechanisms (O'Donnell et al., 2014). Hence, a reduction in Na+ 
intake has clear beneficial cardiovascular effects when resulting in lower arterial blood 
pressure, but a profound further reduction of Na+ intake beyond this point is associated with 
increased cardiovascular events. In the present study a 90% decrease in Na+ intake increased 
kidney QO2 and induced cortical hypoxia, which could provide an explanation for why in 
some cases reducing Na+ intake, without concomitantly reduced arterial blood pressure, is 
associated with poor outcomes.  
In conclusion, the present study demonstrates that low Na+ intake in normotensive conditions 
is associated with RAAS activation and increased kidney QO2 and cortical hypoxia. 
Furthermore, low Na+ diet-induced increased QO2 is mainly associated with increased 
aldosterone-mediated Na+ transport. Given the present results, in the absence of high blood 
pressure, dietary Na+ restriction needs to be carefully monitored as it may be detrimental for 
the kidney. Future experiments are necessary to elucidate the mechanisms operating. An in-
depth study of the angiotensin (1-7)/Mas receptor axis on oxygen metabolism following low 
Na+ diet is highly relevant in this context. Moreover, longitudinal studies to follow-up renal 
function and PO2 along with blood pressure during Na
+ reduction in diet will expand our 
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Figure 2. Mean arterial pressure (A) and renal blood flow (B) in healthy animals fed normal 
(n=13) or low (n=12) Na+ diet, before (baseline) and after angiotensin II AT1 receptor 
blockade using candesartan (4.2 µg/kg). Results expressed as mean ± SD, p<0.05 was 
considered statistically significant. Differences between groups were assessed using two way 
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Figure 3. Oxygen delivery rate (A), oxygen consumption (B) and fractional oxygen extraction (D) in 
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II AT1 receptor blockade using candesartan (4.2 µg/kg). Results expressed as mean ± SD, p<0.05 was 
considered statistically significant. Differences between groups were assessed using two way ANOVA 
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Figure 4. Fractional Na+ excretion (A), transported Na+ (B) and TNa/QO2 (C) in healthy 
animals fed normal (n=12) or low (n=11-12) Na+ diet, before (baseline) and after angiotensin 
II AT1 receptor blockade using candesartan (4.2 µg/kg). Results expressed as mean ± SD, 
p<0.05 was considered statistically significant. Differences between groups were assessed 






Figure 5. Cortical (A) and medullary (B) partial pressure of oxygen in healthy animals fed 
normal (n=13) or low (n=12) Na+ diet, before (baseline) and after angiotensin II AT1 receptor 
blockade using candesartan (4.2 µg/kg). Results expressed as mean ± SD, p<0.05 was 
considered statistically significant. Differences between groups were assessed using two way 









Figure 6. Mean arterial pressure (A) and renal blood flow (B) in healthy animals fed normal 
(n=11) or low (n=9) Na+ diet, before (baseline) and after aldosterone mineralocorticoid 
receptor blockade using CAP (20 mg/kg). Results expressed as mean ± SD, p<0.05 was 
considered statistically significant. Differences between groups were assessed using two way 
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Figure 7. Oxygen delivery rate (A), oxygen consumption (B) and fractional oxygen 
extraction (D) in healthy animals fed normal (n=10-11) or low (n=6-8) Na+ diet, before 
(baseline) and after aldosterone mineralocorticoid receptor blockade using CAP (20 mg/kg). 
Results expressed as mean ± SD, p<0.05 was considered statistically significant. Differences 
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Figure 8. Fractional Na+ excretion (A), transported Na+ (B) and TNa/QO2 (C) in healthy 
animals fed normal (n=10-11) or low (n=6-7) Na+ diet, before (baseline) and after aldosterone 
mineralocorticoid receptor blockade using CAP (20 mg/kg). Results expressed as mean ± SD, 
p<0.05 was considered statistically significant. Differences between groups were assessed 
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Figure 9. Cortical (A) and medullary (B) partial pressure of oxygen in healthy animals fed 
normal (n=9-11) or low (n=9) Na+ diet, before (baseline) and after aldosterone 
mineralocorticoid receptor blockade using CAP (20 mg/kg). Results expressed as mean ± SD, 
p<0.05 was considered statistically significant. Differences between groups were assessed 




Table 1. RT-PCR primer sequences. 
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Table 2. Intrarenal tissue angiotensin II concentration (n=5) and relative mRNA expression 
of angiotensin II AT1a (n=6-9) and AT1b (n=5-6) receptors, in kidney cortex.  
 Normal Na+ Low Na+ 
Angiotensin II (fmol/g) 22.0±6.7 32.8±8.0* 
AT1a (RT expression/β-actin) 1.07±0.43 0.41±0.14* 
AT1b (RT expression/β-actin) 1.08±0.50 2.03±1.12 
Results expressed as mean ± SD, * denotes p<0.05 versus normal Na+. Differences between 






Table 3. Glomerular filtration rate, filtration fraction, urinary electrolyte handling parameters 
and arterial blood gas status in animals fed normal (n=12-13) or low (n=12) Na+ diet during 
baseline and after candesartan. 
 Normal Na+  Low Na+ 
 Baseline Candesartn  Baseline Candesartan 
GFR (mL/min) 1.3±0.6 1.2±0.4  1.1±0.4 1.3±0.3 
FF (%) 23.1±12.1 13.6±5.0*  17.0±9.1 15.3±4.5 
FEK (%) 33.4±12.2 43.6±16.9  22.8±10.6 51.5±14.3*# 
Urinary TBARS (pmol/h) 0.18±0.19 0.22±0.27  0.41±0.34 0.81±0.55*# 
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Plasma Na+ (mmol/L) 138.8±1.6 140.2±2.2  140.0±1.7 140.3±2.2 
Plasma K+ (mmol/L) 4.6±0.3 4.0±0.3#  5.1±0.8* 4.1±0.2# 
Hemoglobin (g/L) 151±8 150±6  151±7 147±7 
Hematocrit (%) 45±2 44±2  44±2 43±2 
Blood pH 7.40±0.02 7.42±0.02*  7.39±0.03 7.41±0.03# 
Blood PO2 (mmHg) 70±5 70±4  74±8 70±6 
Blood PCO2 (mmHg) 50±4 46±4*  48±4 44±3# 
Plasma TBARS (nmol/L) 4.1±1.3 6.4±7.6  3.1±1.7 3.3±1.7 
GFR - glomerular filtration rate; FF - filtration fraction; FEK - fractional urinary excretion of 
K+; PO2 – Partial pressure of O2; PCO2 – Partial pressure of CO2. Results expressed as mean 
± SD, * denotes p<0.05 versus baseline normal Na+; # denotes p<0.05 versus baseline low 
Na+. Differences between groups were assessed using two way ANOVA followed by 
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Table 4. Glomerular filtration rate, filtration fraction, urinary electrolyte handling parameters 
and arterial blood gas status in animals fed normal or low Na+ diet during baseline and after 
CAP. 
 Normal Na+  Low Na+ 
 Baseline CAP  Baseline CAP 
GFR (mL/min) 1.2±0.4 1.4±0.4  1.0±0.4 1.0±0.4 
FF (%) 28.8±10.1 29.8±12.7  24.8±6.7 20.5±6.9 
FEK (%) 18.7±14.8 35.3±31.3  15.4±13.0 44.2±28.9*# 
Urinary TBARS (pmol/h) 0.35±0.17 0.61±0.32  0.65±0.47 0.78±0.59* 
Urinary protein (mg/h) 2.21±0.97 2.14±0.91  2.54±0.71 2.27±0.75 
Plasma Na+ (mmol/L) 137.8±0.8 138.7±2.6  137.4±1.8 138.3±1.7 
Plasma K+ (mmol/L) 4.4±0.3 4.5±0.3  4.9±0.4* 4.8±0.5 
Hemoglobin (g/L) 148±13 145±9  154±11 147±12 
Hematocrit (%) 44±4 43±3  45±3 43±4 
Blood pH 7.40±0.03 7.42±0.03  7.40±0.02 7.41±0.01 
Blood PO2 (mmHg) 66±4 70±6  69±4 71±7* 
Blood PCO2 (mmHg) 53±4 49±2*  49±4* 46±2* 
Plasma TBARS (nmol/L) 2.64±0.74 2.14±0.55  2.28±0.32 2.21±0.44 
GFR - glomerular filtration rate; FF - filtration fraction; FEk - fractional urinary excretion of 
K+; PO2 – Partial pressure of O2; PCO2 – Partial pressure of CO2. Results expressed as mean 
± SD, * denotes p<0.05 versus baseline normal Na+; # denotes p<0.05 versus baseline low 
Na+. Differences between groups were assessed using two way ANOVA followed by 
uncorrected Fisher’s LSD test. 
